Foam Dressings Market By Material (Polyurethane, Silicone), By Application (Chronic Wounds, Acute Wounds), By End User (Hospitals, Home Healthcare, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

List of Tables

The foam dressings market valued for $1,690.84 million in 2022 and is estimated to reach $2,528.45 million by 2032, exhibiting a CAGR of 4.1% from 2023 to 2032.

Foam dressing is a type of advanced wound care dressing used in the treatment of acute and chronic wounds. Foam dressings can be adhesive or non-adhesive in nature which can be used depending on the type of wound. These dressings are designed to manage a wide range of exuding wounds, such as ulcers, surgical wounds, and other injuries. These dressings protect the wound from contamination, reduce the risk of infection, and provide moisture to the wound bed, which increases its adoption in wound care management.

In addition, foam dressings are highly absorbent and help keep the wound area moist, which can promote faster healing. They also have a soft and cushioning effect, providing protection to the wound site and reducing the risk of injury from external factors. Some foam dressings also have a waterproof outer layer, which helps to prevent leakage and maintain a moist wound environment. Such applications increase its demand in the market.

Moreover, foam dressings can be left in place for several days, depending on the severity of exudate. This reduces the need for frequent dressing changes, and thus, can be more comfortable for the patient thereby reducing the risk of infection. Such advantages offered by foam dressing over traditional dressings, increase its adoption by the healthcare community and the patients. This propels the growth of the foam dressings market.

Furthermore, factors such as increase in incidences of conditions such as accidental injuries and chronic wounds drive the growth of the foam dressings market. According to World Health Organization, more than 10 million people suffer from non-fatal injuries every year leading to emergency care visits and hospitalizations, and often result in temporary or permanent disability. In addition, National Hospital Ambulatory Medical Care Survey, 2020, stated that there were 24.2 million emergency department visits for unintentional injuries treatment. This highlights huge incidences of injuries due to various causes, which lead to an increase in demand for foam dressing for wound care management. This boosts the growth of the foam dressings market.

In addition, rise in incidences of chronic ulcers and burn injuries contributes to the expansion of the market. Ulcers, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers, are common chronic wounds that can take a long time to heal. The aging population, sedentary lifestyle, and rise in prevalence of diabetes and obesity have contributed to an increase in the incidence of these types of ulcers. Such conditions often result in slower healing of wounds that require ongoing wound care management. In such cases, foam dressings play a critical role in promoting healing and preventing infection in the wound. These ulcers require surgical debridement and continuous wound care management to promote faster healing and prevent infection, which may involve the use of foam dressings. Foam-based dressings are popular choice for patients with diabetic foot ulcers. Thus, these dressings have a huge demand in the treatment of diabetic foot ulcer, which contribute to the overall growth of the foam dressings market.

Moreover, advancement in foam dressings is also a major factor boosting the market growth. Foam dressings have undergone several advancements in recent years to improve their efficacy and performance. Some of the advancements in foam dressings include the incorporation of antibacterial agents, using silicone adhesive, development of multilayered foam dressings, use nanofiber technology and others. For instance, silver-impregnated foam dressings can be used in outpatient burn clinics as it requires only few dressings until the wound healing. For instance, Mepilex Ag an antimicrobial foam dressing is used for low to medium exuding burns and wounds which can inactivate wound relevant pathogens within 30 minutes. These dressings also allow for home dressing changes and reduce patient discomfort, which is helpful in case of small children. Thus, such advancement in foam dressings, foster the growth of the market.

While foam dressings are an effective wound care product for managing a wide range of wounds, there are some limitations to their use. Some of the limitations of foam dressings includes the early saturation of the foam dressing in case of heavy exudate, the dressing may not be effective in case of dry wounds, may not be suitable for wounds with fragile skin and some patients may have adverse reaction to the material. In addition, Foam dressing products are highly advanced and hence have higher cost than the traditional dressings. Such factors are projected to hinder the market growth.

However, some manufacturers are working to develop more cost-effective foam dressing products to address this issue and increase access to these products in low- and middle-income countries. However, demand for these products is expected to increase in the future as the benefits of foam dressings become more widely recognized among the population and the cost of these products decreases.

In addition, the emerging countries in Asia-Pacific and LAMEA regions, present lucrative opportunities for market players looking to invest in the foam dressings market. These regions are characterized by large populations with high levels of economic growth and increasing healthcare expenditure. In addition, more people in emerging regions are becoming aware of the advanced foam dressings which is anticipated to increase the demand for foam dressing in these regions, thereby boosting the global market growth.

The foam dressings market is segmented on the basis of material, application, end user and region. On the basis of material, the market is bifurcated into polyurethane and silicone. On the basis of application, the market is segregated into chronic wounds and acute wounds. The chronic wound segment is further divided into pressure ulcers, diabetic foot ulcers, venous leg ulcers and others. The acute wound segment is further segmented into burns and trauma and surgical wounds.

On the basis of end user, the market is divided into hospitals, home healthcare and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the market include: 3M Company, Smith and Nephew plc., Convatec Group PLC, B. Braun SE, Cardinal Health Inc., Winner Medical Co., Ltd., Molnlycke Health Care AB, Coloplast, Essity Aktiebolag AB and Covalon Technologies Ltd.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the foam dressings market analysis from 2022 to 2032 to identify the prevailing foam dressings market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the foam dressings market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global foam dressings market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Material

Polyurethane
Silicone

By Application

Chronic Wounds
- Type
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Others
Acute Wounds
- Type
- Burns and Trauma
- Surgical Wounds

By End User

Hospitals
Home Healthcare
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

3M Company
B. Braun SE
Cardinal Health Inc.
Coloplast
Convatec Group PLC
Covalon Technologies Ltd.
Essity Aktiebolag AB
Molnlycke Health Care AB
Smith and Nephew plc.
Winner Medical Co., Ltd.

Product Code: A03765

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Increase in incidences of chronic and acute wounds
  - 3.4.1.2. Advantages offered by foam dressings
  - 3.4.1.3. Advancements in foam dressing products

3.4.2. Restraints
- 3.4.2.1. High cost of foam dressing as compared to traditional dressings

3.4.3. Opportunities
- 3.4.3.1. Surge in demand for advanced foam dressings
- 3.4.3.2. Growth opportunities in developing economies

3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: FOAM DRESSINGS MARKET, BY MATERIAL

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Polyurethane
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Silicone
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: FOAM DRESSINGS MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Chronic Wounds
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.2.4. Chronic Wounds Foam Dressings Market by Type
5.3. Acute Wounds
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.3.4. Acute Wounds Foam Dressings Market by Type

CHAPTER 6: FOAM DRESSINGS MARKET, BY END USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Home Healthcare
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: FOAM DRESSINGS MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Material
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Key market trends, growth factors and opportunities
  - 7.2.5.1.2. Market size and forecast, by Material
  - 7.2.5.1.3. Market size and forecast, by Application
  - 7.2.5.1.4. Market size and forecast, by End User
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Key market trends, growth factors and opportunities
  - 7.2.5.2.2. Market size and forecast, by Material
  - 7.2.5.2.3. Market size and forecast, by Application
  - 7.2.5.2.4. Market size and forecast, by End User
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Key market trends, growth factors and opportunities
  - 7.2.5.3.2. Market size and forecast, by Material
  - 7.2.5.3.3. Market size and forecast, by Application
  - 7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Material
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Key market trends, growth factors and opportunities
  - 7.3.5.1.2. Market size and forecast, by Material
  - 7.3.5.1.3. Market size and forecast, by Application
  - 7.3.5.1.4. Market size and forecast, by End User
  - 7.3.5.2. France
  - 7.3.5.2.1. Key market trends, growth factors and opportunities
  - 7.3.5.2.2. Market size and forecast, by Material
  - 7.3.5.2.3. Market size and forecast, by Application
  - 7.3.5.2.4. Market size and forecast, by End User
  - 7.3.5.3. UK
  - 7.3.5.3.1. Key market trends, growth factors and opportunities
  - 7.3.5.3.2. Market size and forecast, by Material
  - 7.3.5.3.3. Market size and forecast, by Application
  - 7.3.5.3.4. Market size and forecast, by End User
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Key market trends, growth factors and opportunities
  - 7.3.5.4.2. Market size and forecast, by Material
  - 7.3.5.4.3. Market size and forecast, by Application
  - 7.3.5.4.4. Market size and forecast, by End User
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Key market trends, growth factors and opportunities
  - 7.3.5.5.2. Market size and forecast, by Material
  - 7.3.5.5.3. Market size and forecast, by Application
  - 7.3.5.5.4. Market size and forecast, by End User
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Key market trends, growth factors and opportunities
  - 7.3.5.6.2. Market size and forecast, by Material
  - 7.3.5.6.3. Market size and forecast, by Application
  - 7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Material
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Key market trends, growth factors and opportunities
  - 7.4.5.1.2. Market size and forecast, by Material
  - 7.4.5.1.3. Market size and forecast, by Application
  - 7.4.5.1.4. Market size and forecast, by End User
  - 7.4.5.2. China
  - 7.4.5.2.1. Key market trends, growth factors and opportunities
  - 7.4.5.2.2. Market size and forecast, by Material
  - 7.4.5.2.3. Market size and forecast, by Application
  - 7.4.5.2.4. Market size and forecast, by End User
  - 7.4.5.3. India
  - 7.4.5.3.1. Key market trends, growth factors and opportunities
  - 7.4.5.3.2. Market size and forecast, by Material
  - 7.4.5.3.3. Market size and forecast, by Application
  - 7.4.5.3.4. Market size and forecast, by End User
  - 7.4.5.4. Australia
  - 7.4.5.4.1. Key market trends, growth factors and opportunities
  - 7.4.5.4.2. Market size and forecast, by Material
  - 7.4.5.4.3. Market size and forecast, by Application
  - 7.4.5.4.4. Market size and forecast, by End User
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Key market trends, growth factors and opportunities
  - 7.4.5.5.2. Market size and forecast, by Material
  - 7.4.5.5.3. Market size and forecast, by Application
  - 7.4.5.5.4. Market size and forecast, by End User
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Key market trends, growth factors and opportunities
  - 7.4.5.6.2. Market size and forecast, by Material
  - 7.4.5.6.3. Market size and forecast, by Application
  - 7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Material
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Key market trends, growth factors and opportunities
  - 7.5.5.1.2. Market size and forecast, by Material
  - 7.5.5.1.3. Market size and forecast, by Application
  - 7.5.5.1.4. Market size and forecast, by End User
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Key market trends, growth factors and opportunities
  - 7.5.5.2.2. Market size and forecast, by Material
  - 7.5.5.2.3. Market size and forecast, by Application
  - 7.5.5.2.4. Market size and forecast, by End User
  - 7.5.5.3. South Africa
  - 7.5.5.3.1. Key market trends, growth factors and opportunities
  - 7.5.5.3.2. Market size and forecast, by Material
  - 7.5.5.3.3. Market size and forecast, by Application
  - 7.5.5.3.4. Market size and forecast, by End User
  - 7.5.5.4. Rest of LAMEA
  - 7.5.5.4.1. Key market trends, growth factors and opportunities
  - 7.5.5.4.2. Market size and forecast, by Material
  - 7.5.5.4.3. Market size and forecast, by Application
  - 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. 3M Company
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
9.2. Smith and Nephew plc.
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
9.3. Convatec Group PLC
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
9.4. B. Braun SE
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
9.5. Cardinal Health Inc.
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.5.7. Key strategic moves and developments
9.6. Winner Medical Co., Ltd.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
9.7. Molnlycke Health Care AB
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.7.7. Key strategic moves and developments
9.8. Coloplast
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
- 9.8.7. Key strategic moves and developments
9.9. Covalon Technologies Ltd.
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
9.10. Essity Aktiebolag AB
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments